Jonathan P. Mow - 27 Aug 2021 Form 4 Insider Report for PhaseBio Pharmaceuticals Inc

Role
Chief Executive Officer, Director
Signature
/s/ John P. Sharp, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
27 Aug 2021
Net transactions value
+$24,800
Form type
4
Filing time
30 Aug 2021, 17:52:14 UTC
Previous filing
24 May 2021
Next filing
03 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHASQ Common Stock Options Exercise $24,800 +20,000 +16% $1.24* 146,850 27 Aug 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PHASQ Employee Stock Option (right to buy) Options Exercise $0 -20,000 -13% $0.000000 128,767 27 Aug 2021 Common Stock 20,000 $1.24 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All shares underlying this option have vested.